ASX - By Stock
|
CU6 |
Re:
Tlx buys ARTMS - effect on CU-64?
|
|
arthuros
|
47 |
12K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
47
|
12K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Tlx buys ARTMS - effect on CU-64?
|
|
arthuros
|
47 |
12K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
47
|
12K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Tlx buys ARTMS - effect on CU-64?
|
|
arthuros
|
47 |
12K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
47
|
12K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Additional COBRA trial data results
|
|
arthuros
|
9 |
3.2K |
16 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
9
|
3.2K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Half Yearly Report and Accounts
|
|
arthuros
|
2 |
1.0K |
5 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2
|
1.0K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
arthuros
|
329 |
89K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
329
|
89K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: PROPELLER Trial Results
|
|
arthuros
|
26 |
8.9K |
9 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
26
|
8.9K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
arthuros
|
272 |
83K |
13 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
272
|
83K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Resignation of Non-Executive Directors
|
|
arthuros
|
15 |
4.3K |
20 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
15
|
4.3K
|
20
|
|
ASX - By Stock
|
NWC |
Re:
Ann: Maiden Drilling Program Commences at Discus Copper Prospect
|
|
arthuros
|
79 |
18K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
79
|
18K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix ProstACT (TLX591) Expert Forum - Webcast Notification
|
|
arthuros
|
22 |
8.4K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
22
|
8.4K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Bell Potter Healthcare Conference Presentation
|
|
arthuros
|
13 |
4.0K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
13
|
4.0K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity and PSI kick off SAR-bisPSMA Phase III
|
|
arthuros
|
9 |
2.4K |
4 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
9
|
2.4K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity and PSI kick off SAR-bisPSMA Phase III
|
|
arthuros
|
9 |
2.4K |
7 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
9
|
2.4K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
arthuros
|
272 |
83K |
9 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
272
|
83K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
arthuros
|
55 |
14K |
5 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
55
|
14K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Establishes US Center of Excellence for Research
|
|
arthuros
|
26 |
6.5K |
3 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
26
|
6.5K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity update on NorthStar copper-67 production
|
|
arthuros
|
34 |
12K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
34
|
12K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Corporate Presentation
|
|
arthuros
|
1 |
1.4K |
1 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
1
|
1.4K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
arthuros
|
51 |
22K |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
51
|
22K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
arthuros
|
17 |
9.4K |
11 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
17
|
9.4K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
arthuros
|
254 |
114K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
254
|
114K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 50% recruitment milestone reached for prostate cancer trial
|
|
arthuros
|
3 |
1.3K |
8 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
3
|
1.3K
|
8
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Results of Meeting
|
|
arthuros
|
33 |
14K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
33
|
14K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Purchase Order for Multiple APAS Instruments
|
|
arthuros
|
61 |
28K |
2 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
61
|
28K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
arthuros
|
5 |
2.7K |
2 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Corporate Governance Statement
|
|
arthuros
|
6 |
2.2K |
3 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
6
|
2.2K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: CCS Appoints Thermo Fisher as Exclusive US APAS Distributor
|
|
arthuros
|
40 |
13K |
8 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
40
|
13K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
IPO - Clarity Pharmaceuticals Ltd - 25 August 2021 #
|
|
arthuros
|
17 |
14K |
9 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
17
|
14K
|
9
|
|
ASX - By Stock
|
LBT |
Re:
so long 20/21 FY year... onwards and upwards
|
|
arthuros
|
181 |
58K |
2 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
181
|
58K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
arthuros
|
254 |
114K |
0 |
17/04/21 |
17/04/21 |
ASX - By Stock
|
254
|
114K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
arthuros
|
254 |
114K |
1 |
05/04/21 |
05/04/21 |
ASX - By Stock
|
254
|
114K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
fda news pending
|
|
arthuros
|
61 |
22K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
61
|
22K
|
1
|
|
ASX - By Stock
|
BYE |
Re:
Ann: SM58 Operations Update SM58 G2ST First Production
|
|
arthuros
|
96 |
16K |
0 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
96
|
16K
|
0
|
|
ASX - By Stock
|
BYE |
Re:
Ann: SM58 G Platform Installation Process Begins
|
|
arthuros
|
27 |
8.5K |
3 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
27
|
8.5K
|
3
|
|
ASX - By Stock
|
BYE |
Re:
Manipulation
|
|
arthuros
|
5 |
1.7K |
2 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
5
|
1.7K
|
2
|
|
ASX - By Stock
|
BYE |
Re:
Be needing an updated Presentation
|
|
arthuros
|
26 |
20K |
3 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
26
|
20K
|
3
|
|
ASX - By Stock
|
KME |
Re:
Ann: Response to Price Query
|
|
arthuros
|
7 |
20K |
0 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
7
|
20K
|
0
|
|
ASX - By Stock
|
BYE |
Re:
Ann: Appendix 2A (Entitlement Issue)
|
|
arthuros
|
12 |
5.6K |
3 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
12
|
5.6K
|
3
|
|
ASX - By Stock
|
BYE |
Re:
Ann: Appendix 2A (Entitlement Issue)
|
|
arthuros
|
12 |
5.6K |
1 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
BYE |
Re:
Ann: Appendix 2A (Entitlement Issue)
|
|
arthuros
|
12 |
5.6K |
1 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
BYE |
Re:
Ann: Investor Presentation
|
|
arthuros
|
39 |
28K |
2 |
16/11/19 |
16/11/19 |
ASX - By Stock
|
39
|
28K
|
2
|
|
ASX - By Stock
|
LBT Technology |
Re:
Technicals - Good breakout on increasing volume - early days
|
|
arthuros
|
148 |
88K |
12 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
148
|
88K
|
12
|
|
ASX - By Stock
|
BYE |
Re:
Ann: SM58 011 Well Progress Report
|
|
arthuros
|
55 |
29K |
9 |
13/09/19 |
13/09/19 |
ASX - By Stock
|
55
|
29K
|
9
|
|
ASX - By Stock
|
OEL |
Re:
SM71 Production data
|
|
arthuros
|
210 |
161K |
0 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
210
|
161K
|
0
|
|
ASX - By Stock
|
OEL |
Re:
SM71 Production data
|
|
arthuros
|
210 |
161K |
2 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
210
|
161K
|
2
|
|
ASX - By Stock
|
MEL |
Re:
Ann: South Marsh Island 74 D-14 Progress Report
|
|
arthuros
|
99 |
28K |
3 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
99
|
28K
|
3
|
|
ASX - By Stock
|
CXL |
Re:
Ann: CXL - LEILAC commissioning commences
|
|
arthuros
|
28 |
17K |
1 |
04/04/19 |
04/04/19 |
ASX - By Stock
|
28
|
17K
|
1
|
|
ASX - By Stock
|
CXL |
Re:
Ann: CXL - LEILAC commissioning commences
|
|
arthuros
|
28 |
17K |
1 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
28
|
17K
|
1
|
|
ASX - By Stock
|
OEL |
Re:
Ann: Trading Halt
|
|
arthuros
|
86 |
40K |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
86
|
40K
|
0
|
|